Identification of three antiviral inhibitors against Japanese encephalitis virus from library of pharmacologically active compounds 1280.
Japanese encephalitis virus (JEV) can cause severe central nervous disease with a high mortality rate. There is no antiviral drug available for JEV-specific treatment. In this study, a cytopathic-effect-based, high-throughput screening assay was developed and applied to screen JEV inhibitors from Li...
Main Authors: | Jin'e Fang, Leqiang Sun, Guiqing Peng, Jia Xu, Rui Zhou, Shengbo Cao, Huanchun Chen, Yunfeng Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3857149?pdf=render |
Similar Items
-
Roles of TLR3 and RIG-I in Mediating the Inflammatory Response in Mouse Microglia following Japanese Encephalitis Virus Infection
by: Rong Jiang, et al.
Published: (2014-01-01) -
p21-Activated Kinase 4 Signaling Promotes Japanese Encephalitis Virus-Mediated Inflammation in Astrocytes
by: Wen He, et al.
Published: (2017-06-01) -
Japanese encephalitis virus infection induces changes of mRNA profile of mouse spleen and brain
by: Yang Xiaohong, et al.
Published: (2011-02-01) -
Antiviral Activity of Baicalein and Quercetin against the Japanese Encephalitis Virus
by: Jefree Johari, et al.
Published: (2012-12-01) -
Antiviral Activity of Bovine Lactoferrin Against Japanese Encephalitis Virus
by: Yu-Jung Chien, et al.
Published: (2004)